Notably, the nuclear localization of FABP7 has been linked to glioma progression, particularly in oncogene-mutated aggressive subtypes, such as EGFR-amplified [21,22] and IDH1 wild-type GBM [23,24]. The gene discussed is FABP7; the disease is central nervous system cancer.